[go: up one dir, main page]

ES2104358T3 - Inhibidores sililados de acetilcolinesterasa. - Google Patents

Inhibidores sililados de acetilcolinesterasa.

Info

Publication number
ES2104358T3
ES2104358T3 ES94908615T ES94908615T ES2104358T3 ES 2104358 T3 ES2104358 T3 ES 2104358T3 ES 94908615 T ES94908615 T ES 94908615T ES 94908615 T ES94908615 T ES 94908615T ES 2104358 T3 ES2104358 T3 ES 2104358T3
Authority
ES
Spain
Prior art keywords
sililed
acetylcholinesterase inhibitors
compounds
demencies
sililated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94908615T
Other languages
English (en)
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2104358T3 publication Critical patent/ES2104358T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

COMPUESTOS AROMATICOS SILILADOS FLUORADOS QUE POSEEN UNA ACTIVIDAD CONTRA LA COLINESTERASA Y METODOS PARA EL TRATAMIENTO DE DEMENCIAS DEGENERATIVAS MEDIANTE LA UTILIZACION DE ESTOS COMPUESTOS.
ES94908615T 1993-02-16 1994-01-25 Inhibidores sililados de acetilcolinesterasa. Expired - Lifetime ES2104358T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
ES2104358T3 true ES2104358T3 (es) 1997-10-01

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94908615T Expired - Lifetime ES2104358T3 (es) 1993-02-16 1994-01-25 Inhibidores sililados de acetilcolinesterasa.

Country Status (19)

Country Link
EP (2) EP0611769A1 (es)
JP (1) JP3516955B2 (es)
KR (1) KR100336547B1 (es)
CN (1) CN1043575C (es)
AT (1) ATE152725T1 (es)
AU (1) AU672885B2 (es)
CA (1) CA2154870C (es)
DE (1) DE69403068T2 (es)
DK (1) DK0684951T3 (es)
ES (1) ES2104358T3 (es)
FI (1) FI111461B (es)
GR (1) GR3024151T3 (es)
HU (1) HUT72736A (es)
IL (1) IL108623A0 (es)
MX (1) MX9401175A (es)
NO (1) NO305517B1 (es)
NZ (1) NZ262247A (es)
WO (1) WO1994019356A1 (es)
ZA (1) ZA94925B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术（上海）有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
JP5379692B2 (ja) 2006-11-09 2013-12-25 プロビオドルグ エージー 潰瘍、癌及び他の疾患の治療のためのグルタミニルシクラーゼの阻害薬としての３−ヒドロキシ−１，５−ジヒドロ−ピロール−２−オン誘導体
EP2091948B1 (en) 2006-11-30 2012-04-18 Probiodrug AG Novel inhibitors of glutaminyl cyclase
EP2481408A3 (en) 2007-03-01 2013-01-09 Probiodrug AG New use of glutaminyl cyclase inhibitors
EP2142514B1 (en) 2007-04-18 2014-12-24 Probiodrug AG Thiourea derivatives as glutaminyl cyclase inhibitors
AU2010294214B2 (en) 2009-09-11 2015-05-07 Vivoryon Therapeutics N.V. Heterocylcic derivatives as inhibitors of glutaminyl cyclase
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
EP2560953B1 (en) 2010-04-21 2016-01-06 Probiodrug AG Inhibitors of glutaminyl cyclase
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
US11160785B2 (en) 2013-03-15 2021-11-02 Agenebio Inc. Methods and compositions for improving cognitive function
MX2017014774A (es) 2015-05-22 2018-02-15 Agenebio Inc Composiciones farmaceuticas de levetiracetam de liberacion extendida.
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物，其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
CN1043575C (zh) 1999-06-09
FI953851A0 (fi) 1995-08-15
GR3024151T3 (en) 1997-10-31
FI953851L (fi) 1995-08-15
CA2154870A1 (en) 1994-09-01
KR100336547B1 (ko) 2002-11-02
DE69403068T2 (de) 1997-12-11
NO305517B1 (no) 1999-06-14
DK0684951T3 (da) 1997-05-26
CA2154870C (en) 1998-10-27
AU672885B2 (en) 1996-10-17
IL108623A0 (en) 1994-05-30
NZ262247A (en) 1996-01-26
AU6164194A (en) 1994-09-14
HUT72736A (en) 1996-05-28
NO953201L (no) 1995-08-15
EP0684951A1 (en) 1995-12-06
ZA94925B (en) 1994-08-25
JPH08507059A (ja) 1996-07-30
MX9401175A (es) 1994-08-31
WO1994019356A1 (en) 1994-09-01
CN1117733A (zh) 1996-02-28
KR960701068A (ko) 1996-02-24
DE69403068D1 (en) 1997-06-12
EP0684951B1 (en) 1997-05-07
EP0611769A1 (en) 1994-08-24
FI111461B (fi) 2003-07-31
JP3516955B2 (ja) 2004-04-05
ATE152725T1 (de) 1997-05-15
NO953201D0 (no) 1995-08-15

Similar Documents

Publication Publication Date Title
ES2104358T3 (es) Inhibidores sililados de acetilcolinesterasa.
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
MX9308053A (es) COMBINACION DE UN INHIBIDOR DE LA BIOSINTESIS DE COLESTEROL Y UN INHIBIDOR DE ABSORCION DE COLESTEROL DE ß-LACTAMA.
MX9307185A (es) Derivados de carboxilato de indol que inhiben la biosintesis del leucotrieno y composiciones farmaceuticas que los contienen.
EA199800667A1 (ru) Новые фенантридины
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ATE225772T1 (de) Thrombin-inhibitoren
BG102872A (en) 6-phenylpyridyl-3-amine derivatives
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
BG101284A (en) Compounds and methods for cancer treatment
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
BR0311375A (pt) Composição farmacêutica, uso da mesma, e, método para o tratamento de demência ou dano cognitivo suave em um mamìfero
PT885098E (pt) Agente de proteccao da madeira para trabalhos de manutencao
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK0840606T3 (da) Små di- og trivalente molekyler som selectininhibitorer
BR9809495A (pt) "maleimidas aromáticas e métodos para seus usos"
AU8736798A (en) Use of cholinesterase inhibitors for treating attention deficit disorders
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
MX9805290A (es) Utilizacion de inhibidores de la actividad del acido retinoico para tratar las pieles sensibles y/o los daños agudos inducidos por las radiaciones ultravioleta.
IL143516A0 (en) COMPOUNDS AND METHODS FOR MODULATING ACTIVATION OF NF-k-B
CO4600725A1 (es) Composiciones insecticidas sinergisticas
BR9917113A (pt) Agente para tratar de distúrbio de função de células visuais compreendendo um inibidor de interleucina 2, seu método de tratamento e uso

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 684951

Country of ref document: ES